Paydirt
GLUE
Ticker

Monte Rosa Therapeutics, Inc.

GLUE · Healthcare · Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicin…

Monte Rosa Therapeutics, Inc. (GLUE), in the Healthcare sector, has 15 disclosed filings on Paydirt over the trailing twelve months from 7 corporate insiders: 0 purchases and 15 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Jul 16 and filed Jul 17. The most active filer was Filip Janku with 4 filings. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
15
0 buys · 15 sells
Traders, ttm
7
7 insiders
Volume, ttmiDollar value disclosed in the window
$3.3M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Jul 16
Filed Jul 17
ADViAverage daily dollar volume
$21.1M
market data
Share price · 12M
$13.77 (-2.0%)
$25.31$19.41$13.52Nov 10 2025Apr 2Aug 24

Adjusted for splits and dividends.

Volume by month
$1.4M$685K$0Dec 2024Jun 2025Dec 2025Jun 2026Jan 2026 · sells $154KFeb 2026 · sells $179KMar 2026 · sells $455KApr 2026 · sells $245KMay 2026 · sells $284KJun 2026 · sells $1.4MJul 2026 · sells $585K
Buys $0 Sells $3.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
FJ Filip Janku Chief Medical Officer 4 filings · 0 buys, 4 sales MW Markus Warmuth President & CEO 4 filings · 0 buys, 4 sales AM Anthony M. Manning Director 2 filings · 0 buys, 2 sales ST Sharon Townson Chief Scientific Officer 2 filings · 0 buys, 2 sales JC Jennifer Champoux Chief Operating Officer 1 filing · 0 buys, 1 sale ED Edmund Dunn Principal Accounting Officer 1 filing · 0 buys, 1 sale PN Philip Nickson Chief Business & Legal Officer 1 filing · 0 buys, 1 sale
Recent filings
Markus WarmuthSALE President & CEO $220K
9,500 sh × $23.18
Exec Jul 16
Filed Jul 17 · 4:05 PM ET Jennifer ChampouxSALE Chief Operating Officer $102K
4,351 sh × $23.38
Exec Jul 15
Filed Jul 16 · 4:10 PM ET Sharon TownsonSALE Chief Scientific Officer $130K
5,600 sh × $23.25
Exec Jul 6
Filed Jul 7 · 4:41 PM ET Filip JankuSALE Chief Medical Officer $132K
5,407 sh × $24.50
Exec Jun 30
Filed Jul 1 · 4:57 PM ET Anthony M. ManningSALE Director $231K
10,000 sh × $23.11
Exec Jun 29
Filed Jun 30 · 5:30 PM ET Filip JankuSALE Chief Medical Officer $138K
6,000 sh × $22.95
Exec Jun 29
Filed Jun 30 · 5:30 PM ET Filip JankuSALE Chief Medical Officer $882K
41,845 sh across 2 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET Sharon TownsonSALE Chief Scientific Officer $119K
6,000 sh × $19.87
Exec May 29
Filed Jun 1 · 5:30 PM ET Anthony M. ManningSALE Director $180K
10,000 sh × $18.01
Exec May 21
Filed May 22 · 5:30 PM ET Markus WarmuthSALE President & CEO $103K
5,467 sh × $18.92
Exec May 1
Filed May 5 · 5:30 PM ET Markus WarmuthSALE President & CEO $141K
8,000 sh × $17.64
Exec Apr 14
Filed Apr 15 · 5:30 PM ET Philip NicksonSALE Chief Business & Legal Officer $103K
5,845 sh × $17.69
Exec Apr 9
Filed Apr 10 · 5:30 PM ET Edmund DunnSALE Principal Accounting Officer $455K
25,164 sh × $18.10
Exec Feb 27
Filed Mar 2 · 5:30 PM ET Filip JankuSALE Chief Medical Officer $179K
9,189 sh × $19.50
Exec Feb 23
Filed Feb 24 · 5:30 PM ET Markus WarmuthSALE President & CEO $154K
10,135 sh × $15.17
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Versant Venture Capital VI, L.P.SALE 10% owner $1.5M
157,895 sh across 3 lots
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET